Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors

摘要

The present invention provides a compound of Formula I or a pharmaceutically acceptable salt form thereof, wherein A, L¹, R¹, R², R³, R⁴, R⁵, R⁶, and X are as defined herein. The compounds of Formula I have ALK and/or c-Met inhibitory activity, and may be used to treat ALK- or c-Met-mediated disorders or conditions.